TNFRSF11B and pulmonary arterial hypertension: Finally, patients with systolic HF and pulmonary arterial hypertension display low numbers of EPCs and increased levels of osteoprotegerin, implying the deleterious effects of osteoprotegerin in the development of pulmonary ED and worsening the prognosis of systolic HF [107].